Literature DB >> 26806311

General Base-General Acid Catalysis in Human Histone Deacetylase 8.

Sister M Lucy Gantt1, Christophe Decroos2, Matthew S Lee2, Laura E Gullett2, Christine M Bowman2, David W Christianson2,3, Carol A Fierke1.   

Abstract

Histone deacetylases (HDACs) regulate cellular processes such as differentiation and apoptosis and are targeted by anticancer therapeutics in development and in the clinic. HDAC8 is a metal-dependent class I HDAC and is proposed to use a general acid-base catalytic pair in the mechanism of amide bond hydrolysis. Here, we report site-directed mutagenesis and enzymological measurements to elucidate the catalytic mechanism of HDAC8. Specifically, we focus on the catalytic function of Y306 and the histidine-aspartate dyads H142-D176 and H143-D183. Additionally, we report X-ray crystal structures of four representative HDAC8 mutants: D176N, D176N/Y306F, D176A/Y306F, and H142A/Y306F. These structures provide a useful framework for understanding enzymological measurements. The pH dependence of kcat/KM for wild-type Co(II)-HDAC8 is bell-shaped with two pKa values of 7.4 and 10.0. The upper pKa reflects the ionization of the metal-bound water molecule and shifts to 9.1 in Zn(II)-HDAC8. The H142A mutant has activity 230-fold lower than that of wild-type HDAC8, but the pKa1 value is not altered. Y306F HDAC8 is 150-fold less active than the wild-type enzyme; crystal structures show that Y306 hydrogen bonds with the zinc-bound substrate carbonyl, poised for transition state stabilization. The H143A and H142A/H143A mutants exhibit activity that is >80000-fold lower than that of wild-type HDAC8; the buried D176N and D176A mutants have significant catalytic effects, with more subtle effects caused by D183N and D183A. These enzymological and structural studies strongly suggest that H143 functions as a single general base-general acid catalyst, while H142 remains positively charged and serves as an electrostatic catalyst for transition state stabilization.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26806311      PMCID: PMC4747815          DOI: 10.1021/acs.biochem.5b01327

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases.

Authors:  Philip Jones; Sergio Altamura; Raffaele De Francesco; Paola Gallinari; Armin Lahm; Petra Neddermann; Michael Rowley; Sergio Serafini; Christian Steinkühler
Journal:  Bioorg Med Chem Lett       Date:  2008-02-14       Impact factor: 2.823

2.  Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion.

Authors:  Stephanie L Gantt; Samuel G Gattis; Carol A Fierke
Journal:  Biochemistry       Date:  2006-05-16       Impact factor: 3.162

Review 3.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.

Authors:  Paul A Marks; Ronald Breslow
Journal:  Nat Biotechnol       Date:  2007-01       Impact factor: 54.908

4.  Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8.

Authors:  Christophe Decroos; Dane J Clausen; Brandon E Haines; Olaf Wiest; Robert M Williams; David W Christianson
Journal:  Biochemistry       Date:  2015-03-20       Impact factor: 3.162

5.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

Review 6.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.

Authors:  Aleksey G Kazantsev; Leslie M Thompson
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  The pKa values of two histidine residues in human haemoglobin, the Bohr effect, and the dipole moments of alpha-helices.

Authors:  M F Perutz; A M Gronenborn; G M Clore; J H Fogg; D T Shih
Journal:  J Mol Biol       Date:  1985-06-05       Impact factor: 5.469

9.  Binding to thermolysin of phenolate-containing inhibitors necessitates a revised mechanism of catalysis.

Authors:  W L Mock; M Aksamawati
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

10.  Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Authors:  Jane A Plumb; Paul W Finn; Robert J Williams; Morwenna J Bandara; M Rosario Romero; Claire J Watkins; Nicholas B La Thangue; Robert Brown
Journal:  Mol Cancer Ther       Date:  2003-08       Impact factor: 6.261

View more
  23 in total

Review 1.  Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases.

Authors:  Nicholas J Porter; David W Christianson
Journal:  Curr Opin Struct Biol       Date:  2019-02-08       Impact factor: 6.809

Review 2.  Metal-dependent Deacetylases: Cancer and Epigenetic Regulators.

Authors:  Jeffrey E López; Eric D Sullivan; Carol A Fierke
Journal:  ACS Chem Biol       Date:  2016-03-18       Impact factor: 5.100

3.  Purification of metal-dependent lysine deacetylases with consistently high activity.

Authors:  Tasha B Toro; Richard G Painter; Rashad A Haynes; Elena Y Glotser; Melyssa R Bratton; Jenae R Bryant; Kyara A Nichols; Asia N Matthew-Onabanjo; Ashley N Matthew; Derek R Bratcher; Chanel D Perry; Terry J Watt
Journal:  Protein Expr Purif       Date:  2017-08-24       Impact factor: 1.650

4.  Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8.

Authors:  Nicholas J Porter; David W Christianson
Journal:  ACS Chem Biol       Date:  2017-08-30       Impact factor: 5.100

5.  Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.

Authors:  Nicholas J Porter; Adaickapillai Mahendran; Ronald Breslow; David W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

6.  HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides.

Authors:  Carol Ann Castañeda; Noah A Wolfson; Katherine R Leng; Yin-Ming Kuo; Andrew J Andrews; Carol A Fierke
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

7.  Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.

Authors:  Nicholas J Porter; David W Christianson
Journal:  Methods Enzymol       Date:  2019-07-18       Impact factor: 1.600

Review 8.  Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.

Authors:  Stephen A Shinsky; David W Christianson
Journal:  Biochemistry       Date:  2018-03-21       Impact factor: 3.162

Review 9.  Structural aspects of HDAC8 mechanism and dysfunction in Cornelia de Lange syndrome spectrum disorders.

Authors:  Matthew A Deardorff; Nicholas J Porter; David W Christianson
Journal:  Protein Sci       Date:  2016-09-16       Impact factor: 6.725

10.  Structural and Functional Influence of the Glycine-Rich Loop G302GGGY on the Catalytic Tyrosine of Histone Deacetylase 8.

Authors:  Nicholas J Porter; Nicolas H Christianson; Christophe Decroos; David W Christianson
Journal:  Biochemistry       Date:  2016-11-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.